Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT No. ___ )
Healthcare Business Resources, Inc.
(Name of Issuer)
|
Common Stock, par value of $0.001 per share
|
(Title of Class of Securities)
|
|
42240P 106
|
|
||||||
|
|
(CUSIP Number)
|
|
|
|
December 31, 2020
|
|
(Date of Event Which Requires Filing of this
Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
☐ Rule
13d-1(b)
☐ Rule
13d-1(c)
☒ Rule
13d-1(d)
|
*
|
The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect
to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures
provided in a prior cover page.
|
The information required in the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see
the Notes).
Persons who respond to the collection of information contained in
this form are not required to respond unless the form displays a
currently valid OMB control number.
CUSIP No. 42240P 106
|
1.
|
NAME OF REPORTING PERSON:
Meraki Partners, LLC
I.R.S IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY):
|
|||||||||||||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
(a) ☐ (b) ☐
|
|||||||||||||
|
3.
|
SEC USE ONLY
|
|||||||||||||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION:
Florida
|
|||||||||||||
|
NUMBER OF SHARES BENEFICIALLY BY OWNED BY EACH REPORTING PERSON
WITH:
|
5.
|
SOLE VOTING POWER
0
|
||||||||||||
|
6.
|
SHARED VOTING POWER
3,500,000
|
|||||||||||||
|
7.
|
SOLE DISPOSITIVE POWER
0
|
|||||||||||||
|
8.
|
SHARES DISPOSITIVE POWER
3,500,000
|
|||||||||||||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
3,500,000
|
|||||||||||||
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS):
☐
|
|||||||||||||
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
17.86%
|
|||||||||||||
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
OO
|
|||||||||||||
|
1.
|
NAME OF REPORTING PERSON:
Joel Arberman
I.R.S IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY):
|
|||||||||||||
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS)
(a) ☐ (b) ☐
|
|||||||||||||
|
3.
|
SEC USE ONLY
|
|||||||||||||
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION:
United States
|
|||||||||||||
|
NUMBER OF SHARES BENEFICIALLY BY OWNED BY EACH REPORTING PERSON
WITH:
|
5.
|
SOLE VOTING POWER
0
|
||||||||||||
|
6.
|
SHARED VOTING POWER
3,500,000
|
|||||||||||||
|
7.
|
SOLE DISPOSITIVE POWER
0
|
|||||||||||||
|
8.
|
SHARES DISPOSITIVE POWER
3,500,000
|
|||||||||||||
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
3,500,000
|
|||||||||||||
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS):
☐
|
|||||||||||||
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
17.86%
|
|||||||||||||
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
IN
|
|||||||||||||
Item 1.
(a) Name of Issuer:
Healthcare Business
Resources, Inc.
(b)
Address of Issuer’s Principal Executive Offices:
718
Thompson Lane, Suite 108-273, Nashville, Tennessee
37204
Item 2.
(a) Name of Person Filing
This Statement is filed on behalf of the following persons
(collectively, the “Reporting Persons”):
i. Meraki Partners, LLC;
and
ii. Joel Arberman
This Statement relates to shares of
common stock of Healthcare Business Resources, Inc.
directly beneficially owned
by Meraki Partners, LLC (“Meraki”). Joel Arberman is
the controlling person of Meraki. Accordingly, Joel Arberman may be
deemed to indirectly beneficially own the Shares reported
herein.
(b)
Address of principal business office or, if none,
residence:
The address of the
principal business office of each of the Reporting Persons
is 11932
Fountainside Circle, Boynton Beach, FL 33437
(c)
Citizenship:
Meraki
is a Florida limited liability company. Joel Arberman is a citizen
of the United States
(d)
Title of Class of Securities:
Common
Stock, $0.001 par value per share
(e)
CUSIP Number:
42240P
106
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is
a:
Not
Applicable
Item 4.
Ownership.
Provide
the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in
Item 1.
(a) Amount
beneficially owned: 3,500,000
(b) Percent of class:
17.86%
(c) Number of shares as to which the person
has:
(i)
Sole power to vote or to direct the vote: 0
(ii)
Shared power to vote or to direct the vote: 3,500,000
(iii) Sole
power to dispose or to direct the disposition of: 0
(iv) Shared
power to dispose or to direct the disposition of:
3,500,000
Item 5.
Ownership of Five Percent or Less of a Class.
Not
Applicable
Item
6.
Ownership of More than Five Percent on Behalf of Another
Person.
Not
Applicable
Item
7.
Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company or
Control Person.
Not
Applicable
Item
8.
Identification and Classification of Members of the
Group.
Not
Applicable
Item 9.
Notice of Dissolution of Group.
Not
Applicable
Item
10.
Certifications.
Not
Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement
is true, complete and correct.
|
|
February 16, 2021
|
|
|
Date
|
|
|
Meraki Partners, LLC
|
|
|
By: /s/
Joel Arberman
|
|
|
Joel
Arberman, Manager
|
|
|
|
|
|
/s/
Joel Arberman
|
|
|
Joel
Arberman
|
Exhibit A
Joint Filing Agreement
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on
Schedule 13G with respect to the shares of common stock
of Healthcare Business Resources, Inc. dated as of February 16, 2021 is, and any
amendments thereto (including amendments on Schedule 13D) signed by
each of the undersigned shall be, filed on behalf of each of us
pursuant to and in accordance with the provisions of Rule 13d-1(k)
under the Securities Exchange Act of 1934, as
amended.
|
|
February 16, 2021
|
|
|
Date
|
|
|
Meraki Partners, LLC
|
|
|
By: /s/
Joel Arberman
|
|
|
Joel
Arberman, Manager
|
|
|
|
|
|
/s/
Joel Arberman
|
|
|
Joel
Arberman
|